January 21, 2021-February 9, 2024 Watch now: RDCA-DAP and EATRIS Present Rare Disease Drug Develoment Webinar January 21, 2021 | 5:00 p.m. – 6:30 p.m. CET Data Sharing and Analysis to Support Rare Disease Drug Development The Europ
December 2, 2020 COVID-19: Risk Assessment and Mitigation Strategies for the Collection of PRO Data through Clinical Sites – Lessons Learned This webinar provides an update from sponsors and eCOA providers as they discuss lessons learned from managing clinical trials tha
October 27, 2020 Critical Path for Alzheimer’s Disease 2020 Annual Meeting and Regulatory Science Workshop – Virtual October 27, 2020 9:30 a.m. – 1:00 p.m. (US Eastern Time) The Critical Path for Alzheimer’s Disease (CPAD) is a Critical Path I
October 19, 2020 Watch Now: RDCA-DAP 2020 Virtual Workshop Join us for the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) annual workshop and learn more about: RDCA-D
October 10, 2020 Watch Now: Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis Webinar Despite increasing numbers of drug targets and technologies, rare disease drug development is frequently slowed by t
September 13, 2020 The Critical Path Institute: 15 Years of Impact A catalyst in the development of new tools and approaches to advance regulatory science and medical product developm
September 13, 2020 Drug Development and Regulation in the Age of Precision Medicine An introduction and overview of the Critical Path Institute and University of Arizona collaboration and the regulatory sci
September 13, 2020 New Uses for Existing Drugs: Applications for COVID-19 and Valley Fever What is drug repurposing and why is it important? Learn more about the CURE ID web-based app made possible by the National Center
September 13, 2020 How Math, Statistics, and Artificial Intelligence Can be Used to Develop Treatments for Major Diseases: Quantitative Medicine at the Critical Path Institute This presentation focuses on the bridge between a person’s ultimate health in light of being affected by a debilitating disease,
September 6, 2020 Webinar: FDA Drug Topics: CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19 This new webinar from the Center for Drug Evaluation (CDER), Division of Drug Information (DDI) is now available at:
